BOI:EPA
Boiron USA
€19.05
arrow_downward
-1.04%(-0.20) 1 دن
12 نومبر, 5:35:20 PM GMT +1 · EUR
search
تمام علامات
| علامت | قیمت | تبدیلی | % تبدیلی |
|---|
insights_autoBOI کے لیے سرفہرست بصیرتیں تخلیق کی جا رہی ہیں...
کھولیں
€19.10
اعلی
€19.25
کم
€18.85
مارکیٹ کی سرمایہ کاری
33.42 کروڑ
اوسط والیوم
5.04 ہزار
والیوم
660.00
P/E تناسب
12.63
52 ہفتے میں اعلی
€32.25
52 ہفتے کا کم
€16.90
EPS
€1.51
بقایہ شیئرز
1.75 کروڑ
ملازمین کی تعداد
3 ہزار
کھولیں
€19.10
اعلی
€19.25
کم
€18.85
مارکیٹ کی سرمایہ کاری
33.42 کروڑ
اوسط والیوم
5.04 ہزار
والیوم
660.00
P/E تناسب
12.63
52 ہفتے میں اعلی
€32.25
52 ہفتے کا کم
€16.90
EPS
€1.51
بقایہ شیئرز
1.75 کروڑ
ملازمین کی تعداد
3 ہزار
خبریں اور کہانیاں
ویب ذرائع اور خبروں کے پارٹنرز سے
Foreign Policy Journal
·
1 گھنٹہ پہلے
Rocket Lab's (NASDAQ: RKLB) $3.57 Billion Backlog And Neutron Surge Keep Analysts Firmly In Buy Territory
Yahoo Finance
·
52 منٹ پہلے
The S&P 500 Is Hiding a Sneaky Risk. Here's How Investors Can Prepare for Potential Volatility.
TradingView
·
1 گھنٹہ پہلے
Nine Listings Transfer to the NYSE in 2026 Amounting to $500B in Market Cap
پروفائل
Boiron is a manufacturer of homeopathic products, headquartered in France and with an operating presence in 59 countries worldwide. It is the largest manufacturer of homeopathic products in the world. In 2004, it had a workforce of 2,779 and turnover of € 313 million. It is a member of the CAC Small stock index.
In June 2005, the firm acquired Dolisos Laboratories, then the world's second largest manufacturer of homeopathic preparations.
Products of Boiron include mono- and poly-preparations, which Boiron refer to as "proprietary drugs".
Homeopathy is a pseudoscience with no evidence of effectiveness for stated claims or plausible mechanism of medicinal effect, and several class action lawsuits have been filed on behalf of consumers claiming that Boiron's homeopathic products, including Children's Coldcalm and Oscillococcinum, are useless and Boiron's marketing of these products is deceptive. Wikipedia
Boiron USA کے بارے میں